Literature DB >> 9693096

Trichomonas vaginalis thymidine kinase: purification, characterization and search for inhibitors.

S Strosselli1, S Spadari, R T Walker, I Basnak, F Focher.   

Abstract

We report that a thymidine kinase (TK) activity is present in Trichomonas vaginalis and can be separated from the deoxyribonucleoside phosphotransferase. T. vaginalis TK, purified 11200-fold to apparent homogeneity, has a molecular mass of 31500 Da. It phosphorylates not only thymidine (Km 0.18 microM) but also deoxycytidine (Km 0.88 microM) and deoxyuridine (Km 0.14 microM). In contrast with T. vaginalis deoxyribonucleoside phosphotransferase, the TK activity is strongly inhibited by novel deoxyuridine analogues such as 5-methyl-4'-thio-2'-deoxyuridine (MTdU) (Ki 20 nM) and 5-iodo-4'-thio-2'-deoxyuridine (ITdU) (Ki 24 nM). MTdU and ITdU are phosphorylated by T. vaginalis TK in vitro. In vivo they inhibit [3H]thymidine incorporation in T. vaginalis cultured cells and T. vaginalis growth (IC50 7.5 and 24 microM respectively; minimal lethal dose 100 microM). Thus the TK inhibitors described here demonstrate the key role of T. vaginalis TK for protozoal growth and viability and indicate TK as a new target for the design of antitrichomonal drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693096      PMCID: PMC1219655          DOI: 10.1042/bj3340015

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Purine and pyrimidine metabolizing activities in Trichomonas vaginalis extracts.

Authors:  R L Miller; D Lindstead
Journal:  Mol Biochem Parasitol       Date:  1983-01       Impact factor: 1.759

2.  Co-purification of thymidylate kinase and cytosolic thymidine kinase from human term placenta by affinity chromatography.

Authors:  N Tamiya; T Yusa; Y Yamaguchi; R Tsukifuji; N Kuroiwa; Y Moriyama; S Fujimura
Journal:  Biochim Biophys Acta       Date:  1989-03-16

3.  Relaxed enantioselectivity of human mitochondrial thymidine kinase and chemotherapeutic uses of L-nucleoside analogues.

Authors:  A Verri; G Priori; S Spadari; L Tondelli; F Focher
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

4.  N2-phenyldeoxyguanosine: a novel selective inhibitor of herpes simplex thymidine kinase.

Authors:  F Focher; C Hildebrand; S Freese; G Ciarrocchi; T Noonan; S Sangalli; N Brown; S Spadari; G Wright
Journal:  J Med Chem       Date:  1988-08       Impact factor: 7.446

5.  Nucleoside analogs as non-substrate inhibitors of herpes simplex viruses thymidine kinase.

Authors:  F Focher; D Sandoli; C Hildebrand; S Sangalli; G Ciarrocchi; A Rebuzzini; G Pedrali-Noy; R Manservigi; G Wright; N Brown
Journal:  Methods Find Exp Clin Pharmacol       Date:  1989-09

6.  Pyrimidine metabolism in Tritrichomonas foetus.

Authors:  C C Wang; R Verham; S F Tzeng; S Aldritt; H W Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  Affinity chromatography of thymidine kinase from a rat colon adenocarcinoma.

Authors:  E P Kowal; G Markus
Journal:  Prep Biochem       Date:  1976

8.  Purine salvage by Tritrichomonas foetus.

Authors:  C C Wang; R Verham; A Rice; S Tzeng
Journal:  Mol Biochem Parasitol       Date:  1983-08       Impact factor: 1.759

9.  Salvage of pyrimidine nucleosides by Trichomonas vaginalis.

Authors:  C C Wang; H W Cheng
Journal:  Mol Biochem Parasitol       Date:  1984-02       Impact factor: 1.759

10.  The deoxyribonucleoside phosphotransferase of Trichomonas vaginalis. A potential target for anti-trichomonial chemotherapy.

Authors:  C C Wang; H W Cheng
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.